Introduction We focused on the stable gastric pentadecapeptide BPC 157 ( Thus, we suggest that one single application of the NO-synthase (NOS) blocker N(G)-nitro-L-arginine methyl ester (L-NAME) may induce retinal ischemia in rats, and that the stable pentadecapeptide BPC 157 may be the therapy, since it may interact with the NO-system and may counteract various adverse effects of L-NAME application (see In the previous eye research studies, BPC 157 counteracts atropine-mydriasis, but it also opposes an immediate and hour-lasting miotic effect of L-NAME in rats and guinea pigs, and participates in pupil control potentially via NO-mediated and cholinergic mechanisms ( This may be essential for the effective counteraction of the damaging effect of the retrobulbar L-NAME application
Jon Lensing, CEO of OpenLoop, a VC-backed startup that runs telehealth operations for customers under their own brand names, says that his customersincluding large gym chainshave been asking about peptides
BPC-157 contains four proline residues, including an unusual triple-proline sequence that gives the peptide its exceptional stability
These quality claims matter because peptide purity directly affects both safety and efficacy
Su masa molecular es 1419.5 Da, sin puentes disulfuro ni modificaciones post-traduccionales, lo que le confiere estabilidad excepcional en medio cido gstrico (rara entre pptidos teraputicos)
